Table 1

Demographic characteristics of the population in object (all patients, patients affected by postoperative apnea, and patients not affected by postoperative apnea)

All patients(n=122)Apnea (n=12)No apnea (n=110)P value
Birth PCA, d271.06±12.27 (273.00, 264.50–280.00)271.70±16.01 (278.50, 260.75–280.00)271.09±11.92 (273.00, 265.00–280.00)0.92
Birth weight, kg3177.88±465.52 (3200.00, 2940.00–3440.00)3111.25±298.85 (3200.00, 2996.25–3282.50)3185.21±480.77 (3210.00, 2940.00–3495.00)0.60
Comorbidities, n (%)15 (12.29)1 (8.33)14 (12.72)0.66
Age at admission, d35.06±13.54 (33.00, 26.00–42.75)33.08±13.16 (28.00, 25.50–34.00)35.27±13.62 (33.00, 26.00–44.50)0.59
Admission weight, kg3794.30±642.53 (3700.00, 3382.50–4195.00)3592.50±526.07 (3480.00, 3237.50–4005.00)3816.32±652.22 (3705.00, 3400.00–4215.00)0.25
Male gender, n (%)103 (91.96)11 (91.66)92 (83.63)0.47
  • Data are presented as mean±SD (median, IQR).

  • Comorbidities encountered: Down syndrome, atrial septal defect, patent ductus arteriosus, hydronephrosis, and ventricular pre-excitation.

  • Three patients were ex-premature babies (born at 30, 34, and 35+5 postconceptional weeks); none was treated with caffeine or was with bronchodysplasia.

  • P values apply to the apnea vs no apnea comparison (likelihood ratio test). Of the premature patients, one experienced apnea and two did not.

  • d, day; IQR, interquartile range; PCA, postconceptual age; SD, standard deviation.